Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Acquisition of one (1) Bio-Rad CFX Opus 96 Real-Time PCR…

U.S. Department Of Health And Human Services·Maryland

Acquisition of one (1) Bio-Rad CFX Opus 96 Real-Time PCR System for the Laboratory of Receptor Biology and Gene Expression Branch (LRBGE), Center for Cancer Research (CCR), National Cancer Institute (NCI)

Closes 6/15/2026$100k – $200kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking to acquire one Bio-Rad CFX Opus 96 Real-Time PCR System for the Laboratory of Receptor Biology and Gene Expression Branch (LRBGE), Center for Cancer Research (CCR), National Cancer Institute (NCI). The system will replace two existing Bio-Rad CFX96 real-time PCR units that are approximately 10 years old, non-functional, and no longer supported by the manufacturer for repair or service. The replacement instrument is required to restore reliable real-time PCR capability for multiple users and ongoing research programs. • The system must be a Bio-Rad CFX Opus 96 Real-Time PCR System, which provides a 96-well, 5-color plus FRET, network-connected real-time PCR detection platform. • The system must include the CFX Opus 96 base unit, cables, and CFX Maestro Software 2.3 for Windows. • The system will support plate setup, data collection, statistical analysis, and graphing of results. • The replacement platform also offers improved block uniformity and multiplexing compared with the outdated instruments currently being replaced.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

James Law(Contracting Officer)

[email protected]

Key dates

Opened
6/4/2026
Closes
6/15/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
325414
Solicitation №
75N98026Q00517

Budget estimate

$100,000 – $200,000

The estimated budget for this opportunity is between $100,000 and $200,000. This estimation is based on the fact that the system is a specialized laboratory instrument, and the cost of such instruments can range from tens of thousands to hundreds of thousands of dollars. The exact cost will depend on the specific features and requirements of the system.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Tarrant County·Texas

Top match · 73%

Purchase of Genetic Analysis Instrument and Maintenance

Closes 11/5/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

71% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

Mental Health, NYS Office of·New York

71% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

71% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

71% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. National Institutes of Health·United States of America

71% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

Nyc Department of Health and Mental Hygiene·New York

71% match

81627Y0873-Assays, reagents, and consumables for cobas® 5800, 6800v2, 8800v2, MagNa Pure96, and LightCycler systems

Closes 11/2/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

71% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

71% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

71% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

71% match

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Closes 1/25/2028Opened 6/17/2025

U.S. National Institutes of Health·United States of America

71% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. Department Of Health And Human Services·Maryland

71% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

70% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

70% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

Massachusetts Department of Public Health·Massachusetts

70% match

RFR 257030 Certified Oncology Data Specialist

Closes 6/30/2030Opened 3/6/2025

U.S. National Institutes of Health·United States of America

70% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. Bureau of Justice Assistance·United States of America

70% match

BJA FY26 DNA Capacity Enhancement for Backlog Reduction (CEBR)?Competitive Grants Program

Closes 11/3/2026Opened 9/23/2026

LA County Sheriff·California

70% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

U.S. National Institutes of Health·United States of America

70% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

70% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

70% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Closes 1/7/2028Opened 1/11/2022

Massachusetts Department of Public Health·Massachusetts

70% match

RFR 233132 Specialized Laboratory Testing Services

Closes 6/29/2032Opened 3/22/2022